09-10, 12:15–12:45 (Europe/Istanbul), Head & Neck 4 (ICC - B3 Floor - 3B/03)
There has been significant progress in the understanding of the tumor genetics of advanced thyroid cancer, as well as numerous new efficacious targeted therapies. In this session, we will review genomic targets and targeted thearpies for differentiated thyroid cancer, medullary thyroid cancer, and anaplastic thyroid cancer. We will discuss the integration of targeted therapy with surgery for advanced thyroid cancer. We will outline current clinical trials and future directions.
There has been significant progress in the understanding of the tumor genetics of advanced thyroid cancer, as well as numerous new efficacious targeted therapies. In this session, we will review genomic targets and targeted thearpies for differentiated thyroid cancer, medullary thyroid cancer, and anaplastic thyroid cancer. We will discuss the integration of targeted therapy with surgery for advanced thyroid cancer. We will outline current clinical trials and future directions.
I am an Associate Professor of Otorhinolaryngology at Acıbadem University School of Medicine in Istanbul, Turkey. I completed my medical degree and ENT residency at Ankara University and hold a master's degree in Audiology and Speech Disorders. A am a Fellow of the European Board of Otorhinolaryngology – Head and Neck Surgery. My clinical interests include laryngology, voice and swallowing disorders, and HPV-related head and neck diseases.
- Rhinology Free Paper 12
- Union Of European Phoniatricians - Young Phoniatricians Committee
- Function Preservation In Cervical Schwannoma - How And Why To Do Intracapsular Enucleation Surgery.
- Treatment Of Dysplasia: Surgery And Follow-Up
- Voice Evolution Across The Lifespan — Pediatric, Pubertal, Menopausal, And Elderly Voice
- KNOWLEDGE AND ATTITUDES OF OTOLARYNGOLOGISTS REGARDING HUMAN PAPILLOMAVIRUS INFECTION AND VACCINATION
- Vocal Cord Paralysis- A Clinical Update On Diagnosis And Management
Dr. Mark Zafereo is a Professor of Head and Neck Surgery at MD Anderson Cancer Center in Houston, Texas where he is Section Chief of Head and Neck Endocrine Surgery and Associate Medical Director of the Head & Neck Center. Dr. Zafereo serves as Treasurer of the American Thyroid Association, and on the American Head & Neck Society Research and Education Foundation Board of Trustees. He has previously served on the Board of Directors of the American Academy of Otolaryngology-Head and Neck Surgery, and the International Thyroid Oncology Group. Dr. Zafereo leads several national multicenter clinical trials on neoadjuvant therapy followed by surgery for advanced differentiated, medullary, and anaplastic thyroid cancers. He has published significantly on Thyroid and other Head & Neck cancers, speaking nationally and internationally. His clinical practice focuses on patients afflicted with thyroid cancer and parathyroid neoplasms.
- Head And Neck Cancer: How To Manage Depending On Resource Availability?
- Thyroid Surgery 2026: A Joint Session From The World Congress On Thyroid Cancer And The AHNS- Endocrine Section
- Targeted Therapy In The Management Of Thyroid Cancer
- PAN AMERICAN PANEL: Treatment Approaches In Laryngeal Cancer
- Treatment Approaches In Laryngeal Cancer
- American Academy Of Otolaryngology: New Technologies, Advances And Treatment Strategies In Head And Neck Cancer